It is assumed that terminally exhausted T cells do not respond sufficiently to PD-1 therapy since they produce lower levels of effector cytokines, such as interferon-γ and tumor necrosis factor-α, and have an attenuated anti-tumor effect [24]. Here, PDCD1 is linked to neoplasm.